In summary, this study has revealed a novel role for miR-142-3p in regulating breast cancer cell invasiveness, which could at least partially be attributed to a targeting of WASL and ITGAV, and possibly additional cytoskeletal regulators. This evidence concerns the gene ITGAV and breast carcinoma.